Total Funding
94
93
Total FundingPre-Seed raised
Growth Score
7 pts
Heat Score
92 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
40119
Adialante develops low-cost, clinical-grade MRI systems and related services for accessible cancer and neuroimaging screening.
- Efrain Torres: CEO & Co-Founder
- Parker Jenkins: COO & Co-Founder
About the Company
Adialante develops deployable, clinical-grade MRI systems designed to reduce the cost and footprint of traditional scanners. The company focuses on a novel B1 encoding architecture that minimizes or removes B0 gradient coils to enable quieter, portable neuroimaging. Its platform targets cancer and brain screening in clinics and communities that
lack conventional MRI infrastructure. Adialante also offers workshops, innovation courses, and consultation services related to clinical partnerships and healthcare technology development. Customers include healthcare providers, clinics, and research organizations seeking accessible MRI solutions.
